skip to content

Media

Access a wide range of materials relating to our company, our people, innovation, solutions and diagnostics tools or get in touch with us.

Media Releases

“Walk In My Shoes” spotlights the invisible struggles of people living with Multiple Sclerosis (MS)

PDF

Roche Launches Ocrevus® (Ocrelizumab) -a Breakthrough Blockbuster Therapy, Redefining Multiple Sclerosis (MS) Treatment in India

PDF

Roche launches Vabysmo® (faricimab), the first and only bispecific monoclonal antibody for the eye, to treat two leading causes of vision loss

PDF

Roche unveils its first ever Customer Experience Center in Chennai

PDF

Roche and ZS partner to set up dedicated center in Chennai

PDF

Roche Pharma India Launches Patient Support App To Help Patients Seamlessly Navigate Their Care Journey

PDF

Roche expands its Global Analytics and Technology Center of Excellence

PDF

Fighting HER2 + Breast Cancer with innovation and hope

PDF

View all releases

Roche in the news

View all

Roche's Evrysdi (Risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) now available in India.

PDF

Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India

PDF

Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19

PDF

Media Enquiries

For media enquiries, please contact:
[email protected]

©  Roche Products (India) Pvt. Ltd.  

Disclaimer: The images on this website are for representation purpose only and do not indicate actual patient outcomes or the effects of any product.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us at https://www.rocheindia.com/contactOR please call the Roche India Safety Unit on +91-98201 63752or E-mail us at [email protected]